Literature DB >> 23021709

Is there a dose-response relationship for heart disease with low-dose radiation therapy?

Eugene Chung1, James R Corbett, Jean M Moran, Kent A Griffith, Robin B Marsh, Mary Feng, Reshma Jagsi, Marc L Kessler, Edward C Ficaro, Lori J Pierce.   

Abstract

PURPOSE: To quantify cardiac radiation therapy (RT) exposure using sensitive measures of cardiac dysfunction; and to correlate dysfunction with heart doses, in the setting of adjuvant RT for left-sided breast cancer. METHODS AND MATERIALS: On a randomized trial, 32 women with node-positive left-sided breast cancer underwent pre-RT stress single photon emission computed tomography (SPECT-CT) myocardial perfusion scans. Patients received RT to the breast/chest wall and regional lymph nodes to doses of 50 to 52.2 Gy. Repeat SPECT-CT scans were performed 1 year after RT. Perfusion defects (PD), summed stress defects scores (SSS), and ejection fractions (EF) were evaluated. Doses to the heart and coronary arteries were quantified.
RESULTS: The mean difference in pre- and post-RT PD was -0.38% ± 3.20% (P=.68), with no clinically significant defects. To assess for subclinical effects, PD were also examined using a 1.5-SD below the normal mean threshold, with a mean difference of 2.53% ± 12.57% (P=.38). The mean differences in SSS and EF before and after RT were 0.78% ± 2.50% (P=.08) and 1.75% ± 7.29% (P=.39), respectively. The average heart Dmean and D95 were 2.82 Gy (range, 1.11-6.06 Gy) and 0.90 Gy (range, 0.13-2.17 Gy), respectively. The average Dmean and D95 to the left anterior descending artery were 7.22 Gy (range, 2.58-18.05 Gy) and 3.22 Gy (range, 1.23-6.86 Gy), respectively. No correlations were found between cardiac doses and changes in PD, SSS, and EF.
CONCLUSIONS: Using sensitive measures of cardiac function, no clinically significant defects were found after RT, with the average heart Dmean <5 Gy. Although a dose response may exist for measures of cardiac dysfunction at higher doses, no correlation was found in the present study for low doses delivered to cardiac structures and perfusion, SSS, or EF.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23021709      PMCID: PMC5175458          DOI: 10.1016/j.ijrobp.2012.08.002

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer.

Authors:  Lawrence F Paszat; Katherine A Vallis; Veronique M A Benk; Patti A Groome; William J Mackillop; Andreas Wielgosz
Journal:  Radiother Oncol       Date:  2007-02-05       Impact factor: 6.280

Review 2.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

Authors:  M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

3.  Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results.

Authors:  P H Hardenbergh; M T Munley; G C Bentel; R Kedem; S Borges-Neto; D Hollis; L R Prosnitz; L B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-15       Impact factor: 7.038

4.  Distribution of coronary artery stenosis after radiation for breast cancer.

Authors:  Greger Nilsson; Lars Holmberg; Hans Garmo; Olov Duvernoy; Iwar Sjögren; Bo Lagerqvist; Carl Blomqvist
Journal:  J Clin Oncol       Date:  2011-12-27       Impact factor: 44.544

5.  Impact of patient-specific factors, irradiated left ventricular volume, and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer.

Authors:  Elizabeth S Evans; Robert G Prosnitz; Xiaoli Yu; Su-Min Zhou; Donna R Hollis; Terence Z Wong; Kim L Light; Patricia H Hardenbergh; Michael A Blazing; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-15       Impact factor: 7.038

6.  Risk of cardiac death after adjuvant radiotherapy for breast cancer.

Authors:  Sharon H Giordano; Yong-Fang Kuo; Jean L Freeman; Thomas A Buchholz; Gabriel N Hortobagyi; James S Goodwin
Journal:  J Natl Cancer Inst       Date:  2005-03-16       Impact factor: 13.506

7.  Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer.

Authors:  Reshma Jagsi; Jean Moran; Robin Marsh; Kathryn Masi; Kent A Griffith; Lori J Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-09-09       Impact factor: 7.038

8.  Postmastectomy radiotherapy of the chest wall: dosimetric comparison of common techniques.

Authors:  Lori J Pierce; James B Butler; Mary K Martel; Daniel P Normolle; Tod Koelling; Robin B Marsh; Allen S Lichter; Benedick A Fraass
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-04-01       Impact factor: 7.038

9.  Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer.

Authors:  Reshma Jagsi; Kent A Griffith; Todd Koelling; Rachel Roberts; Lori J Pierce
Journal:  Cancer       Date:  2007-02-15       Impact factor: 6.860

Review 10.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Authors:  S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto
Journal:  Lancet       Date:  2011-10-19       Impact factor: 79.321

View more
  25 in total

1.  Dosimetric Considerations in Respiratory-Gated Deep Inspiration Breath-Hold for Left Breast Irradiation.

Authors:  Steve Walston; Allison M Quick; Karla Kuhn; Yi Rong
Journal:  Technol Cancer Res Treat       Date:  2016-07-08

2.  Radiation-induced heart disease: an under-recognized entity?

Authors:  Margot Davis; Ronald M Witteles
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-06

3.  Decreased Lung Perfusion After Breast/Chest Wall Irradiation: Quantitative Results From a Prospective Clinical Trial.

Authors:  Adam L Liss; Robin B Marsh; Nirav S Kapadia; Daniel L McShan; Virginia E Rogers; James M Balter; Jean M Moran; Kristy K Brock; Matt J Schipper; Reshma Jagsi; Kent A Griffith; Kevin R Flaherty; Kirk A Frey; Lori J Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-10-19       Impact factor: 7.038

4.  Hybrid volumetric modulated arc therapy for whole breast irradiation: a dosimetric comparison of different arc designs.

Authors:  Velayudham Ramasubramanian; Karunakaran Balaji; Sitaraman Balaji Subramanian; Krishnamoorthi Sathiya; Moorthi Thirunavukarasu; Chandrasekaran Anu Radha
Journal:  Radiol Med       Date:  2019-01-30       Impact factor: 3.469

5.  Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology.

Authors:  Yu Xie; William J Collins; M William Audeh; Stephen L Shiao; Roberta A Gottlieb; Marc T Goodman; C Noel Bairey Merz; Puja K Mehta
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-12

6.  The Composite Planning Technique in Left Sided Breast Cancer Radiotherapy: A Dosimetric Study.

Authors:  Naveen Kumawat; Anil Kumar Shrotriya; Malhotra Singh Heigrujam; Satendra Kumar; Manoj Kumar Semwal; Anil Kumar Bansal; Ram Kishan Munjal; Deepak Kumar Mittal; Charu Garg; Anil Kumar Anand
Journal:  Eur J Breast Health       Date:  2020-04-01

7.  Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy.

Authors:  Tuomas Virén; Janne Heikkilä; Kimmo Myllyoja; Kristiina Koskela; Tapani Lahtinen; Jan Seppälä
Journal:  Radiat Oncol       Date:  2015-04-08       Impact factor: 3.481

Review 8.  Radiation-induced heart disease: pathologic abnormalities and putative mechanisms.

Authors:  Neil K Taunk; Bruce G Haffty; John B Kostis; Sharad Goyal
Journal:  Front Oncol       Date:  2015-02-18       Impact factor: 6.244

9.  Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease.

Authors:  Delphine Antoni; Shanti Natarajan-Ame; Philippe Meyer; Claudine Niederst; Khalil Bourahla; Georges Noel
Journal:  Radiat Oncol       Date:  2013-05-02       Impact factor: 3.481

10.  Breast conserving treatment for breast cancer: dosimetric comparison of different non-invasive techniques for additional boost delivery.

Authors:  Hilde Van Parijs; Truus Reynders; Karina Heuninckx; Dirk Verellen; Guy Storme; Mark De Ridder
Journal:  Radiat Oncol       Date:  2014-01-27       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.